Menu Search
Equities

Beauty Farm Medical & Health Industry Inc

XC5:FRA

Beauty Farm Medical & Health Industry Inc

Actions
  • Price (EUR)1.88
  • Today's Change-0.05 / -2.59%
  • Shares traded--
  • 1 Year change-11.32%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024 14:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Beauty Farm Medical & Health Industry Inc is an investment holding company that mainly provides beauty and wellness services. The Company's beauty and wellness management services include beauty and health services, aesthetic medical services and subhealth medical services. The Company uses nursing technology, product instruments, quality control processes and service standards to provide beauty and body care services. The Company operates brands such as Beauty Farm, Palaispa, Neology, CellCare, and others. The Company mainly operates its businesses in the domestic market.

  • Revenue in HKD (TTM)2.32bn
  • Net income in HKD232.82m
  • Incorporated2022
  • Employees3.94k
  • Location
    Beauty Farm Medical & Health Industry IncNo.1089 Dongdaming RoadHongkou District, Unit 1206, 12th FloorSHANGHAI ChinaCHN
  • Websitehttp://www.beautyfarm.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.